Entrada Therapeutics, Inc. (TRDA)

Every official Entrada Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Entrada Therapeutics, Inc. documents

• Entrada Therapeutics, Inc. 10-K 2026TRDA 10-K 2026: annual report for fiscal 2026
• Entrada Therapeutics, Inc. 10-K 2025TRDA 10-K 2025: annual report for fiscal 2025
• Entrada Therapeutics, Inc. 10-K 2024TRDA 10-K 2024: annual report for fiscal 2024
• Entrada Therapeutics, Inc. 10-K 2023TRDA 10-K 2023: annual report for fiscal 2023
• Entrada Therapeutics, Inc. 10-K 2022TRDA 10-K 2022: annual report for fiscal 2022
• Entrada Therapeutics, Inc. 10-Q 2026TRDA 10-Q 2026: quarterly report for fiscal 2026
• Entrada Therapeutics, Inc. 10-Q 2025TRDA 10-Q 2025: quarterly report for fiscal 2025
• Entrada Therapeutics, Inc. 10-Q 2024TRDA 10-Q 2024: quarterly report for fiscal 2024
• Entrada Therapeutics, Inc. 10-Q 2023TRDA 10-Q 2023: quarterly report for fiscal 2023
• Entrada Therapeutics, Inc. 10-Q 2022TRDA 10-Q 2022: quarterly report for fiscal 2022
• Entrada Therapeutics, Inc. 8-K 2026TRDA 8-K 2026: current report for fiscal 2026
• Entrada Therapeutics, Inc. 8-K 2025TRDA 8-K 2025: current report for fiscal 2025
• Entrada Therapeutics, Inc. 8-K 2024TRDA 8-K 2024: current report for fiscal 2024
• Entrada Therapeutics, Inc. 8-K 2023TRDA 8-K 2023: current report for fiscal 2023
• Entrada Therapeutics, Inc. 8-K 2022TRDA 8-K 2022: current report for fiscal 2022
• Entrada Therapeutics, Inc. DEF 14A 2026TRDA DEF 14A 2026: proxy statement for fiscal 2026
• Entrada Therapeutics, Inc. DEF 14A 2025TRDA DEF 14A 2025: proxy statement for fiscal 2025
• Entrada Therapeutics, Inc. DEF 14A 2024TRDA DEF 14A 2024: proxy statement for fiscal 2024
• Entrada Therapeutics, Inc. DEF 14A 2023TRDA DEF 14A 2023: proxy statement for fiscal 2023
• Entrada Therapeutics, Inc. DEF 14A 2022TRDA DEF 14A 2022: proxy statement for fiscal 2022
• Entrada Therapeutics, Inc. Form 4 2026TRDA Form 4 2026: insider trading filing for fiscal 2026
• Entrada Therapeutics, Inc. Form 4 2025TRDA Form 4 2025: insider trading filing for fiscal 2025
• Entrada Therapeutics, Inc. Form 4 2024TRDA Form 4 2024: insider trading filing for fiscal 2024
• Entrada Therapeutics, Inc. Form 4 2023TRDA Form 4 2023: insider trading filing for fiscal 2023
• Entrada Therapeutics, Inc. Form 4 2022TRDA Form 4 2022: insider trading filing for fiscal 2022
• Entrada Therapeutics, Inc. S-1 2026TRDA S-1 2026: registration statement for fiscal 2026
• Entrada Therapeutics, Inc. S-1 2025TRDA S-1 2025: registration statement for fiscal 2025
• Entrada Therapeutics, Inc. S-1 2024TRDA S-1 2024: registration statement for fiscal 2024
• Entrada Therapeutics, Inc. S-1 2023TRDA S-1 2023: registration statement for fiscal 2023
• Entrada Therapeutics, Inc. S-1 2022TRDA S-1 2022: registration statement for fiscal 2022
• Entrada Therapeutics, Inc. 13F 2026TRDA 13F 2026: institutional holdings for fiscal 2026
• Entrada Therapeutics, Inc. 13F 2025TRDA 13F 2025: institutional holdings for fiscal 2025
• Entrada Therapeutics, Inc. 13F 2024TRDA 13F 2024: institutional holdings for fiscal 2024
• Entrada Therapeutics, Inc. 13F 2023TRDA 13F 2023: institutional holdings for fiscal 2023
• Entrada Therapeutics, Inc. 13F 2022TRDA 13F 2022: institutional holdings for fiscal 2022

More companies